JPRN-UMIN000037944尚未招募2 期
ATG-based HLA haploidentical stem cell transplantation (HCM regimen) for recurrent or refractory round-cell-type sarcoma in AYA generation: prospective phase II study - ATG-based HLA haploidentical stem cell transplantation (HCM regimen) for recurrent or refractory round-cell-type sarcoma in AYA generation
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine0 个研究点目标入组 16 人开始时间: 2019年10月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 39years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) serum Cre >2.0 mg/dl 2) serum T-bil >2.0 mg/dl 3) serum AST and/or ALT >200 mg/dl 4) EF <40% by ultracardiograpgy 5) SpO2 <90% in ambient air 6) PS (ECOG score) 3-4 Not always excluded if data are elevated due to original disease and are expected to improve by treatment
研究者
相似试验
已完成
不适用
HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic diseasesAcute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Secondary acute myelogenous leukemia Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)JPRN-UMIN000002069Hematology, Osaka City University, Graduate School of Medicine17
已完成
2 期
HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic malignancies (OCU13-3)Acute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)JPRN-UMIN000011293Osaka City University35
已完成
2 期
HLA-haploidentical allogeneic stem cell transplantation for Adult T-cell leukemia/lymphoma (ATL/L) and refractory aggressive lymphomaAdult T-cell leukemia/lymphoma (acute type and lymphoma type) Malignant lymphoma (aggressive hodgkin and non-hodgkin lymphoma)JPRN-UMIN000002606Hematology, Osaka City University, Graduate School of Medicine17
已完成
1 期
HLA haploidentical stem cell transplantation using myeloablative regimen including ATGhematologic malignanciesJPRN-UMIN000004904Hyogo College of Medicine20
招募中
2 期
HLA haploidentical hematopoietic stem cell transplantation, Phase II trialhematologic malignancies, bone marrow failure syndrome, and other hematological disorders which requires hematopoietic stem cell transplantationJPRN-UMIN000027049Hyogo College of Medicine100